HealthCare Institute of New Jersey Issues Statement on Inflation Reduction Act’s New List of Medicines Subject to Price Controls
Trenton, August 15, 2024 ― The HealthCare Institute of New Jersey released the following statement concerning the Administration’s announcement of the next selected prescription medicines subject to government price setting: “Government price controls are not the way to lower health care costs. These price controls run counter to America’s longstanding global leadership on innovation – […]
HealthCare Institute of New Jersey Elects New Board Leadership
Trenton, August 5, 2024 ― The HealthCare Institute of New Jersey has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1. Leo Farber, Vice President and Head of U.S. Government Affairs, Novartis, was elected Chair of the Board. Mr. Farber joined Novartis in 2014 and has […]
Federal Reports Find PBMs Drive Up Drug Costs, Pocket the Money. Patients Need Protection.
Chrissy Buteas Special to the USA TODAY NetworkJuly 30, 2024 A new study by the Federal Trade Commission as well as a report issued by the House Oversight Committeehave confirmed what many policymakers and health policy experts have been saying for the last few years: little-known middlemen in the healthcare sector, called pharmacy benefit managers, or […]
HealthCare Institute of New Jersey Holds “Diversity in the Healthcare Workforce” Panel Featuring Congresswoman Bonnie Watson Coleman
Trenton, July 17, 2024 ― The HealthCare Institute of New Jersey held a panel discussion focused on diversity in the healthcare workforce on Tuesday, July 16, 2024, featuring Congresswoman Bonnie Watson Coleman as the keynote speaker and panelist. The panel discussion was moderated by Assembly Health Committee Chairman Dr. Herb Conaway. HINJ, a trade association […]
New HINJ CEO Buteas Eager for Honest Discussion on Costs of Drug Development, Prescription Prices (ROI-NJ.com)
Veteran lobbyist says less than 10% of health care dollar is spent on prescription drugs — percentage that has not changed since 1960s June 4, 2024 ― Chrissy Buteas quickly and succinctly rattled off why she is excited to be the new CEO of the HealthCare Institute of New Jersey. “Iconic industry that saves lives,” she […]
For New Head of Healthcare Institute, Retention is as Important as Attraction When it Comes to Industry Growth in State (ROI-NJ.com)
Buteas is all about helping N.J. grow biopharma and medical technology sectors, but stresses need to acknowledge, appreciate global companies already here June 4, 2024 ― Whether she’s at the New Jersey pavilion or walking the floor at this week’s BIO International Conference in San Diego, Chrissy Buteas — the new CEO of the HealthCare […]
Balancing Current and Future Patients
Steve Issenman | May 29, 2024 America’s elected officials – Republicans and Democrats, from the Northeast and Southwest, representing big states and small – all care deeply about making the world a better place. But while their perspectives may sharply differ on many issues, they or a loved one – a parent, a child, a […]
OPINION: Beware of New Regs
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. May 20, 2024 – New Jersey has long been home to some of the world’s leading research-based biopharmaceutical companies. Many have made New Jersey a base for their global, North American, or U.S. operations. Aside from their contributions to human health and patients worldwide, our […]
Chrissy Buteas: Saving lives around the world by finding cures in New Jersey
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. Trenton, April 29, 2024 – New Jersey – home to the Sopranos, the Jersey Shore, full-service gas stations and the long-running debate over pork roll versus Taylor ham. Gritty, smart as hell, and loyal to our Jets . . . or Giants . . . […]
HealthCare Institute of New Jersey Announces the Appointment of Chrissy Buteas as President and Chief Executive Officer
Trenton, NJ – March 26, 2024 – Chris Lepore, Chair of the Board of Trustees of the HealthCare Institute of New Jersey (HINJ) (www.hinj.org) and Vice President, U.S. State Affairs, Johnson & Johnson, today announced the appointment of Christine “Chrissy” Buteas as HINJ’s next President and Chief Executive Officer following the retirement of long-time President […]